Viewing Study NCT00578292

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:57 PM
Ignite Modification Date: 2026-05-17 @ 11:01 PM
Study NCT ID: NCT00578292
Status: TERMINATED
Last Update Posted: 2020-05-01
First Post: 2007-12-19
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO
Sponsor: Baylor College of Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Thalassemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None transfusion-dependent View
None homozygous b0/+-thalassemia View
None severe variants of b0/+-thalassemia View
None transfusion View
None iron chelating agents View
None severe View
None transfusion-dependent homozygous View